Fitch Ratings says that pharmaceutical companies will face significant operating challenges during 2011, as the expiration of significant drug patents is set to erase record levels of revenues and earnings, coupled with pressure from government cost containment in the US and Europe. The agency’s outlook for the sector in 2011 is [...]